PMDA — authorised 29 June 2020
- Marketing authorisation holder: GlaxoSmithKline
- Status: approved
🇯🇵 Jesduvroq in Japan
PMDA authorised Jesduvroq on 29 June 2020
Marketing authorisation
Jesduvroq in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in Japan
Frequently asked questions
Is Jesduvroq approved in Japan?
Yes. PMDA authorised it on 29 June 2020.
Who is the marketing authorisation holder for Jesduvroq in Japan?
GlaxoSmithKline holds the Japanese marketing authorisation.